Publication | Closed Access
Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial
94
Citations
32
References
2018
Year
Rheumatoid DisorderVasculitisAutoimmune DiseaseImmunologyImmunotherapyMedicineProspective 52-Week TrialRheumatoid Arthritis
| Year | Citations | |
|---|---|---|
Page 1
Page 1